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ABSTRACT
INTRODUCTION: Chronic kidney disease (CKD) is characterized by a reduced rate of glomerular 
filtration (GF), under 60 mL/min/1.73 m2, and/or laboratory data, and/or image data for kidney damage, 
present for more than 3 months. According to recent data, nearly 8.7% of the world population suffer from 
CKD with different etiology. CKD is a progressive health condition that can result in an end stage renal 
disease (ESRD). 
The quality of life (QoL) of these patients is of utmost importance and is related to their functional activity, 
well-being and overall perception of their health in a physical, psychological and social aspect. A direct 
link between QoL, morbidity rate and death rate exists. It has been established that patients with CKD have 
a significantly lower QoL compared to healthy people, which becomes clearer during the more advanced 
stages of the disease. Physical activity decreases progressively with the progression of kidney disease.
RESULTS: Sociodemographic, clinical and laboratory risk factors have been established in the population 
of dialysis patients, which definitely leads to a change in QoL. Malnutrition, which is observed in patients 
with CKD, can also contribute to a decline in their quality of life. Its occurrence results from a reduced 
food intake, increased protein consumption and altered endocrine function of the kidneys. Oral intake of 
nutrients raises the chances of treating protein-energy wasting (PEW) in patients with ESRD.
CONCLUSION: Conducting dietary consultations, as well as preparing individual diets to meet a patient’s 
specific needs, will increase their quality of life.
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INTRODUCTION 
Malnutrition is a major characteristic of chron-
ic kidney disease (CKD), which emerges in varying 
degrees depending on the stage of the disease. In be-
tween 40% and 70 % of the patients who are experi-
encing end stage renal disease (ESRD), malnutrition 
is discovered as a result of various factors that include 
loss of appetite, digestion and nutrient assimilation 
disorder, metabolic acidosis, and emotional stress (1).
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Baltzan and Shoker think that at least two types 
of malnutrition could appear in dialysis patients. The 
first type (type 1) is itself associated with the uremic 
syndrome or with factors related to uremia, such as 
reduced physical activity, ineffective dialysis proce-
dure, dietary restrictions, and psychosocial factors. 
Baltzan and Shocker et al., in 1998, report on mod-
erate reduction in the levels of serum albumin on ac-
count of reduced intake of protein and energy, taking 
into consideration uremic toxicity, which causes ure-
mic anorexia with respective reduction in protein ca-
tabolism (11,12). On the other hand, a more distinc-
tive hypoalbuminemia, the significantly increased 
oxidation stress, as well as the increased protein ca-
tabolism, characterize the other type of malnutrition 
(type 2). Significant comorbid states, such as chronic 
heart failure and infectious complications, are com-
mon with this type of malnutrition, which can be 
proved through higher levels of C-reactive protein 
(CRP) and anti-inflammatory cytokines (13). 
Reasons for Protein-Energy Wasting (PEW)
1. Reduced protein intake: anorexia, dysregulation 
in the circulating mediators connected with 
appetite, uremic toxins, dietary restrictions, 
changes in the organs (participating in the nu-
trients intake), depression, inability to take in or 
prepare food; 
2. Hypermetabolism: increased energy consump-
tion (inflammation), increased circulating anti-
inflammatory cytokines, higher levels of CRP;
3. Secondary factors: related to obesity, insulin re-
sistance, hormone disorders (insulin  resistance 
in CKD, increased glucocorticoid activity);
4. Metabolic acidosis;
5. Reduced physical activity;
6. Reduced anabolism: reduced nutrient intake, re-
sistance to growth hormone/IGF-1, shortage of 
testosterone, lower levels of the thyroid gland 
hormones, accompanying diseases (diabetes, 
heart failure, etc.), and lower quality of life;
7. Dialysis: loss of nutrients during the dialysis 
procedure – dialysis membranes, hemodialy-
sis lines, dialysis solutions, hypermetabolic pro-
cesses connected to the loss of remaining kid-
ney function.
The quality of life (QoL) for these patients is im-
portant and related to their functional activity, well-
being, and general perception of their health in a 
physical, psychological and social aspect (2,3). There 
is a direct link between QoL, morbidity rate, and 
death rate. Malnutrition that is observed in peritone-
al dialysis patients contributes significantly to the re-
duced QoL they lead (4,5,6).
Protein-Energy Wasting (PEW)
Protein-energy wasting (PEW) is a term sug-
gested by the International Society of Renal Nutri-
tion and Metabolism (ISRNM). It includes numer-
ous nutritional and catabolic changes, which appear 
during a chronic kidney disorder, and is linked to 
an increased morbidity and death rate. Insufficient 
food intake (the actual malnutrition), due to a lack of 
appetite and food restrictions, contributes to its oc-
currence and results from reduced food import, in-
creased protein consumption, and a change in the 
endocrine function of the kidneys. Changes caused 
by uremia are also accountable, such as increased en-
ergy consumption, persistent inflammation, acido-
sis, and numerous metabolic disorders (7,8). They, in 
turn, lead to a state of hypermetabolism that causes 
excess catabolism of muscle tissue and fat deposits. 
For patients with chronic kidney disease, poor physi-
cal activity, weakness, as well as the dialysis itself, ad-
ditionally contribute to PEW. Research using classic 
markers for nutritional status shows that nearly 18-
75% of the patients with CKD, who are subjected to 
chronic dialysis treatment, show indications of pro-
tein-energy malnutrition or malnutrition syndrome 
– cachexia.
Protein energy waste is a state of reduced pro-
tein and energy resources (body proteins and fats). 
This anomaly is often linked with reduced function-
al capacity and metabolic load. Protein or energy de-
pletion could be a result of wrong diet, while in kid-
ney diseases, conditions/syndromes, which lead to 
weight loss unrelated to reduced nutrients intake, 
have been discovered (9). These are unusual inflam-
matory processes, transient and intercurrent catabol-
ic diseases, nutrient loss during dialysis procedures, 
endocrine disorders (resistance to insulin, growth 
hormone and insulin-like growth factor-1 (IGF-1), 
hyperglucagonemia, hyperparathyroidism), as well 
as blood loss in the hemodialysis system (10).
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MATERIALS AND METHODS
Markers tracking quality of life are presented in 
this article.
A regular diet plays an important role in re-
ducing the morbidity rate and death rate for patients 
with CKD. The recommendations given by the Kid-
ney Disease Improving Global Outcomes (KDIGO) 
(2012) suggest that pre-dialysis patients with CKD G 
4-5 should go on a protein diet of 0.8 g/kg/day, which 
ensures a quality diet. A diet consisting of a low-
er intake of proteins is useful when controlling hy-
perphosphatemia, metabolic acidosis, and hyperka-
liemia. Protein restriction could prevent CKD from 
progressing by hemodynamically mediated decrease 
in inner glomerular pressure, as well as from chang-
es in the expression of cytokines. The hemodynamic 
effects of the protein-induced hyperfiltration result 
from changes in the hormones (such as glucagon and 
IGF-1), changes in the renin-angiotensin system and 
intrarenal effects, including tubuloglomerular feed-
back (14,15).
On the other hand, for patients with advanced 
CKD who are subjected to a hemodialysis treatment 
the protein intake has to be 1.5 g/kg/day, while for 
patients who are subjected to a continuous ambula-
tory peritoneal dialysis the protein intake is about 
2 g/kg/day. It is important to note that the protein 
has to have high biological value (BV). Hemodialy-
sis patients lose considerable amounts of amino acids 
during the procedure itself, and these losses are even 
higher for patients who are subjected to a continuous 
ambulatory peritoneal dialysis (CAPD). A suitable 
and adequate dialysis dose (dialysis adequacy) signif-
icantly prevents the catabolism of proteins. 
Hypoalbuminemia
Hypoalbuminemia is an important marker of 
malnutrition, increased death rate and higher mor-
bidity for patients undergoing kidney-replacement 
treatment. It has been established that a low level of 
serum albumin is an independent predictor of gen-
eral and cardiovascular death for patients subjected 
to CAPD. In a number of studies and analysis, it has 
been proved that the levels of serum albumin could 
be low even in visibly well-nourished hemodialysis 
patients. The concentration of serum albumin is reg-
ulated by a number of factors – by protein malnutri-
Fig. 1. Schematic presentation of the causes and emergence of protein energy malnutrition in kidney diseases (14)
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tion mostly, inflammation and external losses. The 
latter is important, particularly for patients subjected 
to continuous dialysis, where owing to the transperi-
toneal processes, the protein losses could reach 20 
g/24h. The inflammation causes hypoalbuminemia 
by suppressing the albumin synthesis as well as by 
transferring albumin from the vessel to the extravas-
cular space. The combination of inflammation and 
reduced protein intake could lead to a significant de-
crease in the concentration of serum albumin. The 
pro-inflammatory cytokines also cause malnutri-
tion and cardiovascular diseases. This is not unex-
pected as serum albumin and CRP participate in the 
same process during the acute stage of the inflam-
mation. It has been determined that moderately in-
creased plasma concentrations of CRP are connected 
to a higher risk of cardiovascular diseases for healthy 
individuals. Increased levels of CRP correlate with 
cardiovascular morbidity rate, ischemic brain insult, 
and other causes for elderly people. A direct link be-
tween malnutrition, increased levels of CRP, and ath-
erosclerosis for dialysis patients has been proved. 
Human plasma consists of various antioxidant 
biomolecules, and what is of interest is serum albu-
min, which is a major active antioxidant in the plas-
ma. In this way, its low levels, which are related to 
malnutrition and/or inflammation, could increase 
the atherogenesis by increasing oxidation stress. In 
1999, Soejima et al. showed that hypoalbuminemia 
accelerates lipid peroxidation of the erythrocyte 
membrane for hemodialysis patients. The mecha-
nism through which higher oxidation stress could 
accelerate atherogenesis is by affecting the endothe-
lium function (16).
Atherosclerosis
Atherosclerosis is connected with endothelium 
dysfunction and reduced biological presence of ni-
trogen oxide (NO). Both peritoneal dialysis patients 
and hemodialysis patients have impaired endotheli-
um vasodilatation. The formation of NO, along with 
serum albumin, has relaxing properties regarding 
the endothelium. In this way, low levels of albumin 
could be associated with impaired endothelium-de-
pendent vasodilatation. In 1999, Kin et al. demon-
strate correlations between serum albumin, CRP and 
serum markers for endothelium function, and prove 
that albumin infusion does not normalize endothe-
lium function. Therefore, their discoveries firmly in-
dicate that the connection between low levels of se-
rum albumin and endothelium dysfunction could 
be secondary with reference to other factors. In 1999, 
Kessler et al. report that in rabbits the pro-inflam-
matory mediators inhibit the formation hyperpolar-
ization factor dependent on endothelium, which can 
contribute to endothelium dysfunction (17).
Hypoalbuminemia and inflammation are im-
portant predictors of death in dialysis patients, while 
malnutrition complications for them are a common 
cause of morbidity and hospitalization. It is estab-
lished that malnutrition constitutes less than 5% of 
deaths in patients with CKD, while atherosclerotic 
cardiovascular disease is the most common cause of 
mortality in the dialysis population. This is the rea-
son for the presence of a syndrome consisting of mal-
nutrition, inflammation and atherosclerosis (MIA 
syndrome) in some patients with CKD. Inflamma-
tion is more common in malnourished hemodialysis 
patients, while in 2013, Ikizler et al. show that the nu-
trition status and the inflammation response are in-
dependent predictors of hospitalization of these pa-
tients. All of this shows that nutrition and inflamma-
tion markers are closely connected with cardiovas-
cular diseases in CKD. Therefore, increased levels of 
pro-inflammatory cytokines are the connection be-
tween the high circulation of the inflammation, mal-
nutrition and cardiovascular diseases in patients.
CRP and Pro-Inflammatory Cytokines
Serum levels of CRP reflect the generation of 
pro-inflammatory cytokines [interleukin-1, (IL-1), 
interleukin-6, (IL-6) and tumor necrosis factor-α 
(TNF-α)], which are reported to be increasing in pa-
tients with CKD. High levels of pro-inflammato-
ry cytokines could cause muscle loss by stimulat-
ing protein catabolism, by decreasing albumin syn-
thesis as well as by inhibiting appetite. In addition, it 
has been observed that IL-1, TNF-α, and endotoxins 
could induce catabolism of muscle protein by stim-
ulating ketoacidotic dehydrogenase, which leads to 
higher oxidation of amino acids. As a result, the in-
creased plasma levels of pro-inflammatory cytokines 
predict hypoalbuminemia and death in patients who 
are subjected to a replacement treatment of the kid-
ney function. 
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CRP is a marker convenient to use in daily 
practices with regard to the evaluation of the inflam-
matory status of patients with CKD (18). Each rise 
in CRP by 1 mg/L leads to 30 kcal of daily energy 
consumption. Not only is the inflammation catabol-
ic, but it is also responsible for anorexia. For dialysis 
patients, the increase in serum CRP is inversely con-
nected to appetite. In 2008, K. Zadeh et al. report of 
an inverse connection between appetite and serum 
CRP in 331 patients (19,20). 
Visfatin
Visfatin is a new factor generated by adipocytes, 
also sensitive to inflammation, which could play a 
part in anorexia in patients with CKD. Based on the 
responses to an appetite questionnaire given by 246 
hemodialysis patients in Sweden, high-level visfatin 
(e.g. over 40 ng/mL) is linked to reduced appetite and 
lower plasma amino acid profile. 
Oxidation Stress
Oxidation stress, which occurs during the pres-
ence of excess production of free radicals or low lev-
els of antioxidant, is an important factor that con-
tributes to the development of endothelium dysfunc-
tion and atherogenesis. Patients with malnutrition in 
stage G3-G4 of CKD have lower plasma levels of vi-
tamin E, which suggests insufficient intake of anti-
oxidants when the food intake is low (21). Accord-
ing to recent data, inflammation is connected with 
an increase in oxidation stress as a result of activating 
monocytes in patients with CKD. Because of that, it 
could be argued that the increase in oxidation stress 
contributes to a higher occurrence of cardiovascular 
diseases in malnourished patients with CKD. 
RESULTS / DISCUSSION 
Quality of life (QoL) is related to a patient’s 
functional activity, their wellbeing and overall per-
ception of health in a physical, psychological and so-
cial aspect. In chronic diseases, more particularly in 
CKD, there is a close link between QoL, morbidity 
rate, and mortality rate. It has been established that 
patients with CKD have a significantly lower QoL 
compared to healthy people, which is more distinct 
during the pre-dialysis stages (stages G4 and G5) 
(22). A patient’s age is also of importance, especially 
for those in advanced age (23). 
In their publication from 2011, Maria C. Cruz 
et al. report that QoL is reduced in all stages of CKD. 
Physical activity decreases progressively in all stages 
of kidney disease. Malnourished patients have a sig-
nificantly lower level of physical functionality com-
pared to well rehabilitated patients. This shows that 
malnutrition in the early stages of CKD leads to a re-
duced ability to perform daily physical needs, as well 
as walking. The symptoms and the severity of kidney 
diseases are statistically and/or clinically more dis-
tinct in malnourished patients, which leads to low-
er QoL (24). Patients with malnutrition report of a 
higher influence of uremic symptoms, such as mus-
cle weakness and pain, headaches, spasms, skin ir-
ritation, dyspnea, dizziness, lack of appetite, exces-
sive thirst, limb numbness, memory problems, dim 
eyesight, nausea, etc. Sociodemographic, clinical and 
laboratory risk factors have been determined in the 
dialysis population (level of education, sex, person-
al approach, professional activity, age, levels of he-
moglobin, serum levels of phosphorus, diabetes and 
accompanying diseases), which could also contrib-
ute to an altered QoL. Some of the variables (e.g. age, 
sex, and ethnicity) are difficult and slow to impact. It 
is necessary to put effort into reducing the influence 
of those factors, which could positively affect a pa-
tient’s condition, such as treating anemia (increasing 
the levels of hemoglobin), and adequate treatment of 
accompanying diseases (25).
Both nutrition status and inflammatory re-
sponse are independent predictors leading to a rise in 
the number of hospitalizations of patients with CKD. 
CRP values, serum albumin, pre-albumin, as well as 
the remaining inflammation factors, are reliable and 
important indictors of forecasting an impending dis-
ease. The mortality and morbidity rates for patients 
with ESRD are high. 
CONCLUSION
According to researches, conducted so far, the 
lifespan of patients with ESRD in the USA is between 
20 and 25 years shorter than the average for the pop-
ulation in the USA for the age group of over 45. The 
connection between malnutrition, inflammation, 
and QoL in patients with CKD is clearly established. 
The provision of good food status and adequate 
treatment could lead to the improvement and main-
tenance of good QoL. Through personalized, well-
timed and appropriate therapy, as well as through 
the prevention of symptoms caused by reduced kid-
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ney function, the progression of the disease could be 
slowed down significantly. For these patients, pre-
vention and early diagnosis constitute the prevention 
of progression, complications, and unfavorable out-
come of CKD. 
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